1. Home
  2. PODD vs JBL Comparison

PODD vs JBL Comparison

Compare PODD & JBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • JBL
  • Stock Information
  • Founded
  • PODD 2000
  • JBL 1966
  • Country
  • PODD United States
  • JBL United States
  • Employees
  • PODD N/A
  • JBL N/A
  • Industry
  • PODD Medical/Dental Instruments
  • JBL Electrical Products
  • Sector
  • PODD Health Care
  • JBL Technology
  • Exchange
  • PODD Nasdaq
  • JBL Nasdaq
  • Market Cap
  • PODD 23.8B
  • JBL 23.6B
  • IPO Year
  • PODD 2007
  • JBL 1993
  • Fundamental
  • Price
  • PODD $340.29
  • JBL $216.15
  • Analyst Decision
  • PODD Strong Buy
  • JBL Strong Buy
  • Analyst Count
  • PODD 18
  • JBL 8
  • Target Price
  • PODD $334.50
  • JBL $222.75
  • AVG Volume (30 Days)
  • PODD 532.2K
  • JBL 1.3M
  • Earning Date
  • PODD 11-06-2025
  • JBL 09-25-2025
  • Dividend Yield
  • PODD N/A
  • JBL 0.15%
  • EPS Growth
  • PODD N/A
  • JBL N/A
  • EPS
  • PODD 3.32
  • JBL 5.11
  • Revenue
  • PODD $2,359,500,000.00
  • JBL $28,514,000,000.00
  • Revenue This Year
  • PODD $29.18
  • JBL $1.61
  • Revenue Next Year
  • PODD $18.09
  • JBL $5.71
  • P/E Ratio
  • PODD $102.63
  • JBL $42.25
  • Revenue Growth
  • PODD 26.00
  • JBL N/A
  • 52 Week Low
  • PODD $225.37
  • JBL $103.82
  • 52 Week High
  • PODD $353.50
  • JBL $232.84
  • Technical
  • Relative Strength Index (RSI)
  • PODD 59.53
  • JBL 56.03
  • Support Level
  • PODD $336.00
  • JBL $212.81
  • Resistance Level
  • PODD $351.94
  • JBL $217.15
  • Average True Range (ATR)
  • PODD 8.16
  • JBL 4.67
  • MACD
  • PODD -1.50
  • JBL 1.25
  • Stochastic Oscillator
  • PODD 46.37
  • JBL 84.00

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About JBL Jabil Inc.

Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.

Share on Social Networks: